 Z17 |
 |
Estrogen, and other hormones and factors receptor status  |
| |
| Notes |
Use one code, as available, for each receptor: Z17.0, Z17.1, Z17.2-, Z17.3-
|
| CodeFirst |
malignant neoplasm, such as:
malignant neoplasm of breast (C50.-)
malignant neoplasm of ovary (C56.-)
|
|
| |
 Z17.0 |
|
Estrogen receptor positive status [ER+] |
| |
|
|
| |
| Z17.1 |
|
Estrogen receptor negative status [ER-] |
| |
|
|
| |
| Z17.2 |
|
Progesterone receptor status |
| |
| Z17.21 |
|
Progesterone receptor positive status |
| |
|
| | |
| Z17.22 |
|
Progesterone receptor negative status |
| |
|
| |
| |
| Z17.3 |
|
Human epidermal growth factor 2 receptor |
| |
| Z17.31 |
|
Human epidermal growth factor receptor 2 positive status |
| |
|
| | |
| Z17.32 |
|
Human epidermal growth factor receptor 2 negative status |
| |
|
| |
| |
| Z17.4 |
|
Combined receptor status |
| |
| Notes |
Assign a code from subcategory Z17.4- when only a combined receptor status is documented
|
|
| |
| Z17.41 |
|
Hormone receptor positive |
| |
|
| |
| Z17.410 |
|
Hormone receptor positive with human epidermal growth factor receptor 2 positive status |
| |
|
| | |
| Z17.411 |
|
Hormone receptor positive with human epidermal growth factor receptor 2 negative status |
| |
|
| | | |
| Z17.42 |
|
Hormone receptor negative |
| |
|
| |
| Z17.420 |
|
Hormone receptor negative with human epidermal growth factor receptor 2 positive status |
| |
|
| | |
| Z17.421 |
|
Hormone receptor negative with human epidermal growth factor receptor 2 negative status |
| |
| HR- with HER2- | | TNBC | | Triple negative breast cancer |
|
| | |